Edition:
United Kingdom

Humanwell Healthcare Group Co Ltd (600079.SS)

600079.SS on Shanghai Stock Exchange

10.10CNY
14 Dec 2018
Change (% chg)

¥-0.36 (-3.44%)
Prev Close
¥10.46
Open
¥10.42
Day's High
¥10.45
Day's Low
¥10.04
Volume
7,895,200
Avg. Vol
7,524,104
52-wk High
¥18.55
52-wk Low
¥10.04

Latest Key Developments (Source: Significant Developments)

Humanwell Healthcare's Shareholders To Unload Up To 2 Percent Stake
Friday, 30 Nov 2018 

Nov 30 (Reuters) - Humanwell Healthcare Group Co Ltd <600079.SS>::SAYS SHAREHOLDERS PLAN TO UNLOAD UP TO 2 PERCENT STAKE IN THE COMPANY BETWEEN DEC 24, 2018 AND MAY 31, 2019.  Full Article

Humanwell Healthcare's Unit Reprimanded By Environmental Authority Due To Pollution
Monday, 26 Nov 2018 

Nov 26 (Reuters) - Humanwell Healthcare Group Co Ltd <600079.SS>::SAYS UNIT REPRIMANDED BY ENVIRONMENTAL AUTHORITY DUE TO POLLUTION.  Full Article

Humanwell Healthcare Group Says 9-Month Net Profit Down 66.5 Percent Y/Y
Monday, 29 Oct 2018 

Oct 29 (Reuters) - Humanwell Healthcare Group Co Ltd <600079.SS>::SAYS 9-MONTH NET PROFIT DOWN 66.5 PERCENT Y/Y.  Full Article

Humanwell Healthcare Group sells stake in Wuhan biopharmaceuticals firm for $102.4 mln
Wednesday, 27 Jun 2018 

June 27(Reuters) - Humanwell Healthcare Group Co Ltd <600079.SS>:Says it sold all 20 percent stake in Wuhan biopharmaceuticals firm for $102.4 million to CSL BEHRING ASIA PACIFIC LTD.  Full Article

Humanwell Healthcare Group to pay A shares div for FY 2017 on July 5
Wednesday, 27 Jun 2018 

June 27 (Reuters) - Humanwell Healthcare Group Co Ltd <600079.SS> ::* Says it will pay cash dividend of 0.16 yuan(before tax)/A share for 2017 to shareholders of record on July 4.* The company's shares will be traded ex-right and ex-dividend on July 5 and the dividend will be paid on July 5.  Full Article

Humanwell Healthcare Group unit receives FDA approval for new drug Potassium Chloride Extended-Release Tablets
Tuesday, 26 Jun 2018 

June 26(Reuters) - Humanwell Healthcare Group Co Ltd <600079.SS>:Says co's Yichang-based unit received FDA approval for new drug Potassium Chloride Extended-Release Tablets .Unit will be able to sell the new drug in the United States after receiving the FDA approval.  Full Article

Humanwell Healthcare Group unit passes FDA approval for new drug Bupropion Hydrochloride Extended-Release Tablets
Wednesday, 20 Jun 2018 

June 20(Reuters) - Humanwell Healthcare Group Co Ltd <600079.SS> ::* Says its controlling unit received FDA approval for new drug Bupropion Hydrochloride Extended-Release Tablets from U.S Food and Drug Administration .* The new drug is used for treatment of major depressive disorder and seasonal affective disorder.* Unit will be able to sell the new drug in the United States after receiving the FDA approval.  Full Article

Humanwell Healthcare's 2017 Net Profit Up, Plans Debt Financing Instruments And Commercial Paper
Wednesday, 11 Apr 2018 

April 11 (Reuters) - Humanwell Healthcare Group Co Ltd <600079.SS>::SAYS 2017 NET PROFIT UP 148.5 PERCENT Y/Y AT 2.1 BILLION YUAN ($334.18 million).SAYS IT PLANS TO ISSUE UP TO 2.0 BILLION YUAN DEBT FINANCING INSTRUMENTS, 4.0 BILLION YUAN COMMERCIAL PAPER.  Full Article

Humanwell Healthcare Group unit receives FDA approval
Wednesday, 4 Apr 2018 

April 4(Reuters) - Humanwell Healthcare Group Co Ltd <600079.SS>:Says co's wholly owned unit Epic Pharma, LLC received FDA approval for its Hydrocodone Bitartrate and Acetaminophen Tablet (medicine) from U.S Food and Drug Administration .Says unit will be able to sell this medicine in the United States after receiving the FDA approval.  Full Article

Humanwell Healthcare Group issues 2018 first tranche short-term financing notes worth 1 bln yuan
Wednesday, 24 Jan 2018 

Jan 24 (Reuters) - Humanwell Healthcare Group Co Ltd <600079.SS>:Says it issued 2018 first tranche short-term financing notes worth 1 billion yuan with a term of 365 days and coupon rate of 5.49 percent .Bank of China Limited served as the main underwriter .  Full Article

Ansell shares pummelled as rubber price, tariffs weigh on outlook

SYDNEY, Aug 20 Australian rubber products maker Ansell Ltd warned on Monday that rising raw material costs and the prospect of tariffs on U.S. exports to China could stall earnings growth next year, sending shares plunging 10 percent.